GLPHubglpresearchhub.com
Read-only archive. GLP Research Hub is a static community record — nothing here is for sale, no account is needed, and no vote you cast is counted. Why?
Single comment threadYou are looking at one branch of [Discussion] can we stop arguing about EU until somebody posts a number — 23 comments in the full submission. View in context.
687
c/glp1eu·submitted 3 months ago by u/kaplan_meier_kim

[Discussion] can we stop arguing about EU until somebody posts a number

Discussionbranch of 13 comments

can we stop arguing about EU until somebody posts a number — that is what I am asking, and I have already read the wiki twice. A supply notice in one member state made the front page here and had no effect at all where I am. Kept the prescription and the receipt for a claim, purely because a thread here told me to.…

Read the full submission and all 23 comments →

This branch

13 comments, started 3 months ago
u/erez_yilmaz0 points·3 months ago

Pack sizes and presentations differ between member states, so a headline price is not comparable until it is normalised to a common quantity.

replysharereportpermalink
u/kaplan_meier_kimOP1 point·3 months ago

cross-border prescription rules exist and they are narrower than people think

replysharereportpermalink
u/patient_labslip_log1 point·3 months ago

the EMA authorises, member states decide who pays

replysharereportpermalink
u/kaplan_meier_kimOP1 point·3 months ago

keep the prescription and the receipt, both matter for claims

replysharereportpermalink
u/kaplan_meier_kimOP1 point·3 months ago

The variation between pharmacies inside my own country was larger than the variation I had been chasing across the border.

replysharereportpermalink
u/no_refunds_nr0 points·3 months ago

Pharmacy margins and dispensing fees are regulated nationally, which explains price differences that otherwise look arbitrary.

replysharereportpermalink
load more comments (7) →

← back to the whole thread

About c/glp1eu

European access, country by country: prescription routes, reimbursement reality, pharmacy stock, EMA notices and the fact that "EU rules" is usually a national question wearing a European hat.

32kmembers
62submissions
Apr 2024created
submissions / month, last year
Sponsored

PeptideMeter Analytics

Independent testing plus vendor-level trend data. Community-funded, unaffiliated.

peptidemeter.com
c/glp1eu rules
  1. Tag your country in the title. Bare "EU" questions get a template reply.
  2. Pricing posts need the date and the currency.
  3. EMA and national agency claims need a citation.
  4. Independent community. Nobody here sells anything, and anyone who tries is banned.
  5. Not medical advice. Describe what you did; never prescribe to a stranger.
  6. Claims need evidence. Batch numbers, dated screenshots, independent test reports, or a citation.
  7. No referral links, discount codes or affiliate URLs. Permanent ban, no appeal.
  8. No contact handles, wallet addresses or tracking numbers — they identify people.
  9. Be recognisably decent. Disagree hard, insult nobody.
Moderators
Volunteers. Unpaid, unaffiliated, and reachable through modmail only.
Before you read on

Several compounds discussed on GLP Research Hub are sold for research use only and are not approved for human use anywhere. Nothing here is medical advice and none of it is written by your clinician. If a post reads like an instruction, treat it as a description of what one stranger did.